All Type of News
Celltrion’s personnel reshuffle in C-level
Celltrion Group will perform a personnel reshuffle to establish a base to expand and accelerate its global biopharmaceutical business.
According to Celltrion Group, Celltrion promoted CO-CEO Woo-Sung Ki and Hyung-Gi ...
‘Artificial Intelligence’ over hypothesis-driven study
An opinion was raised that development of new drugs must go towards AI, not the conventional hypothesis-driven studies.
At the ‘Artificial Intelligence, New Paradigm of New Drug Development’ seminar on the 7th, Profe...
Government invested KRW 3 trillion into R&D in health & medical field
The pharmaceutical industry has reportedly invested KRW 3 trillion for the last 3 years, which was the period of the ‘1st Health and Medical Technology Promoting Plan’ from the year of 2013.
The Korea Health Industry...
MOHW to proceed 10th meeting with medical field as scheduled late March
Assuming they would like to continue having a sincerely conversation with the medical field about the National Health Insurance Coverage Extension Plan(Moon Jae-In Care), the Ministry of Health and Welfare announced t...
Pharma field’s heart ‘pounding’ over whether prosecution would put a hand on CSOs for illegal rebates
While pharmaceutical companies have had sharp attention to whether the prosecution would put a hand on CSOs(contract sales organizations), which has been suspicious of being a window for illegal rebates, it is anticip...
Pharmaceutical industry has high potentials for Korea-India cooperation
The pharmaceutical industry has been chosen as a potential industry for Korean small & medium companies to cooperate between Korea and India. An analysis result showed it a rare case where Korea and India might genera...
‘Edarbi’ co-marketed by Takeda Pharmaceuticals & Dong-A ST enters Seoul National University Hospital
‘Edarbi’ jointly sold by Takeda Pharmaceuticals and Dong-A ST has entered Seoul National University Hospital.
At the Drug Committee on the last 2nd, Seoul National University let various drugs, like ‘Edarbi.’ LG Chem...
11 Korean-developed medicines break the U.S. and EU wall of approval
11 medicines which were developed by Korean pharmaceutical companies after 2013 have reportedly been well sold as breaking the wall of approval of the U.S. and European Union.
According to the Ministry of Health and ...
“It’s about to announce the 2018 plans for the 2nd pharmaceutical general plans”
The Ministry of Health and Welfare said they would announce the 2018 enforcement plans for the 2nd pharmaceutical general plans. They promised valuation of new drugs and tax support for innovative growth of pharmaceut...
Korean pharmas getting closer to U.S. market, changing market trend within 4 to 5 years
Pharmaceutical companies dreaming to become a global pharmaceutical company are focusing on creating new drug pipelines. This is because it seems they might be decided to become one by how successful their new drug pi...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
